Sentiment Trading

Aptevo Therapeutics Inc., a biotechnology company focused on oncology and hematology therapeutics, is navigating the challenges of the biotech industry while showing signs of recovery and investor interest in its potential to deliver impactful treat…

Aptevo Therapeutics Inc’s stock has plummeted nearly 99% from its peak, raising questions about the company’s future and the viability of its flagship program, APVO711.